281

The article presents data on the implementation of patients ' medical recommendations for taking antihypertensive drugs. At the same time, antihypertensive agents recommended by doctors for the treatment
of arterial hypertension were analyzed. It is shown that among patients with arterial hypertension, there
was an unfavorable situation regarding the fair use of antihypertensive drugs. It is shown that only 40% of
patients suffering from hypertension regularly take antihypertensive drugs. The fndings indicate that doctors are more likely to prescribe beta-blockers
 

  • Internet havola
  • DOI
  • UzSCI tizimida yaratilgan sana 02-02-2020
  • O'qishlar soni 263
  • Nashr sanasi 14-10-2019
  • Asosiy tilIngliz
  • Sahifalar113-116
English

The article presents data on the implementation of patients ' medical recommendations for taking antihypertensive drugs. At the same time, antihypertensive agents recommended by doctors for the treatment
of arterial hypertension were analyzed. It is shown that among patients with arterial hypertension, there
was an unfavorable situation regarding the fair use of antihypertensive drugs. It is shown that only 40% of
patients suffering from hypertension regularly take antihypertensive drugs. The fndings indicate that doctors are more likely to prescribe beta-blockers
 

Ўзбек

Antihipertensif dori-darmonlarni qabul qilish bo'yicha bemorlarning tibbiy tavsiyalarini bajarish
bo'yicha ma'lumotlar keltirilgan. Shu bilanbirga, arterial hipertensiyani davolash uchun vrachlar tomonidan tavsiya etilgan antihipertensif dorilar tahlil qilindi. Arterial hipertensiyaga uchragan bemorlar orasida antihipertensif dorilar etarli darajada foydalanish bilan bog'liq salbiy holat borligi ko'rsatilgan. Shu
bilanbirga, arterial hipertensiyabilanog'riganbemorlarningfaqat 40% antihipertensif dorilarni muntazam
ravishda qabul qilishadi. Olingan ma'lumotlarga ko'ra, shifokorlar beta-blokatorlarni ko'proq tavsiya qilishadi.
 

Русский

Приводятся данные о выполнении пациентами врачебных рекомендаций по приёму
антигипертензивных средств. Вместе с тем, проанализированы рекомендованные врачами
антигипертензивные средства для лечения артериальной гипертензии. Показано, что среди
больных артериальной гипертензии сложилась неблагоприятная ситуация в отношении
адекватного применения антигипертензивных препаратов. При этом показано, что только 40%
больных страдающих артериальной гипертензией регулярно принимают антигипертензивные
препараты. Полученные данные указывают на то, что врачи в большей степени назначают
бетта-адреноблокаторы.
 

№ Muallifning F.I.Sh. Lavozimi Tashkilot nomi
1 QALANDAROVA U.A. Urgench branch of Tashkent medical academy
№ Havola nomi
1 1. OdutayoA, WongCX, HsiaoAJ, etal. Atrial fbrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ 2016;354:i4482 10.1136/bmj.i4482
2 2. Mente A, O’Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet 2016;388:465–75. 10.1016/S0140- 6736(16)30467-6
3 3. Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular fltration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 2015;3:514–25. 10.1016/ S2213-8587(15)00040-6
4 4. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434–44. 10.2337/diacare.16.2.434
5 5.Kayumov U.K., Kalandarova U.A., Ibadova M.U., Ismatova M.N.The formation of a hard «end points» for various risk factors. Journal of Biomedicine and Practice, 2019, vol. 1, issue 1, pp.80–85. https://www.tadqiqot.uz/wp-content/uploads/2019/05/ biomedicine-2019-1/biomedicine-2019-01.pdf http://dx.doi.org/10.26739/2181-9297-2019-1-14.
6 6. Hao Wang, Ying Ba, Run-Ce Cai, and Qian Xing. Association between diabetes mellitus and the risk for major cardiovascular outcomes and all-cause mortality in women compared with men: a meta-analysis of prospective cohort studies. BMJ Open. 2019; 9(7): e024935. Published online 2019 Jul 17. doi: 10.1136/bmjopen-2018-024935. https://europepmc.org/articles/ pmc6661591#fragment-fulltext
7 7. Каюмов У.К. Изучение некоторых внутренних болезней при метаболическом синдроме и различных категориях гипергликемии. Евразийский научный журнал. 2017. -№2. – С. 405-408. https://elibrary.ru/item.asp?id=28872542
8 8. Абдухакимова Н.А., Хатамова Д.Т., Каюмов У.К. Частота и уровни некоторых основных компонентов метаболического синдрома у больных подагрой при сахарном диабете и нарушенной толерантности к глюкозе. Врачаспирант. - 2009. - №3. – С. 182-183. http://www.wisesoft.ru/load4317.htm
9 9. Mancia G., Fagard R., Narkiewicz K., Redón J., Zanchetti A., Böhm M., Christiaens T., Cifkova R., De Backer G., Dominiczak A., Galderisi M., E. Grobbee D., Jaarsma T., Kirchhof P., E. Kjeldsen S., Laurent S., J. Manolis A., M. Nilsson P., Miguel Ruilope L., E. Schmieder R., Sirnes P., Sleight P., Viigimaa M., Waeber B., Zannad F. 2013 ESH/ESC GUIDELINES FOR THE MANAGEMENT OF ARTERIAL HYPERTENSION. Russian Journal of Cardiology. 2014;(1):7-94. https://doi. org/10.15829/1560-4071-2014-1-7-94.
Kutilmoqda